ArticleOncoTargets and therapy2021

Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma.

Chang-Shuai Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.